APPLICATION
ANDA090005
TYPE
ANDA
ORIGINAL APPROVAL
2011-04-20
LATEST ACTION
2020-07-27
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
NAFCILLIN SODIUMPrescription
NAFCILLIN SODIUM EQ 10GM BASE/VIAL · INJECTABLE · INJECTION
Approval history
2020-07-27Labeling · Supplement 6 · standardAP
2020-07-27Labeling · Supplement 7 · standardAP
2020-07-27Labeling · Supplement 5 · standardAP
2013-01-15Labeling · Supplement 4 · standardAP
2012-09-04Labeling · Supplement 2AP
2011-04-20OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.